(a) For the Beaumont-Port Arthur, Bexar County, Dallas-Fort
Worth, El Paso, and Houston-Galveston-Brazoria areas, the following
recordkeeping requirements shall apply.
(1) The owner or operator of any pharmaceutical manufacturing
facility which utilizes a surface condenser to control emissions of
volatile organic compound (VOC) from process units affected by §115.531(a)(1)
of this title (relating to Emission Specifications) shall install
and maintain monitors to continuously measure and record the outlet
gas temperature to ensure proper functioning in accordance with design
specifications.
(2) The owner or operator of any pharmaceutical manufacturing
facility which utilizes a vapor recovery system to satisfy the requirements
of §115.531(a) of this title (relating to Emission Specifications)
or §115.532(a) of this title (relating to Control Requirements)
shall:
(A) install and maintain monitors to continuously measure
and record operational parameters of all required control devices
as necessary to ensure the proper functioning of those devices in
accordance with design specifications, including:
(i) the exhaust gas temperature of direct-flame incinerators
and/or the gas temperature immediately upstream and downstream of
any catalyst bed;
(ii) the exhaust gas VOC concentration of any carbon
adsorption system, as defined in §115.10 of this title (relating
to Definitions), to determine if breakthrough has occurred;
(iii) the total amount of VOC recovered by carbon adsorption
or other solvent recovery systems during a calendar month; or
(iv) the daily emission rate of VOC from the control
device;
(B) maintain a record of the dates and reasons for
any maintenance and repair of the required control devices and the
estimated quantity and duration of VOC emissions during such activities.
(3) The owner or operator of any pharmaceutical manufacturing
facility which is exempted from the requirements in accordance with
the provisions of §115.537(a) of this title (relating to Exemptions)
shall maintain a record of the following information, as appropriate:
(A) the vapor pressure of materials transferred at
loading facilities, stored in tanks, or processed in centrifuges and
filters; and
(B) the daily emissions rate of VOC.
(4) The owner or operator of any affected pharmaceutical
manufacturing facility shall maintain records of any testing conducted
at an affected facility in accordance with the provisions specified
in §115.535(a) of this title (relating to Testing Requirements).
(5) The owner or operator of any affected pharmaceutical
manufacturing facility shall maintain all records at the affected
facility for at least two years and make such records available upon
request to representatives of the executive director, United States
Environmental Protection Agency (EPA), or local air pollution control
agency.
(b) For Gregg, Nueces, and Victoria Counties, the following
recordkeeping requirements shall apply.
(1) The owner or operator of any pharmaceutical manufacturing
facility which utilizes a surface condenser to control emissions of
VOC from process units affected by §115.531(b)(1) of this title
(relating to Emission Specifications) shall install and maintain monitors
to continuously measure and record the outlet gas temperature to ensure
proper functioning in accordance with design specifications.
(2) The owner or operator of any pharmaceutical manufacturing
facility which utilizes a vapor recovery system to satisfy the requirements
of §115.531(b) of this title (relating to Emission Specifications)
or §115.532(b) of this title (relating to Control Requirements)
shall:
(A) install and maintain monitors to continuously measure
and record operational parameters of all required control devices
as necessary to ensure the proper functioning of those devices in
accordance with design specifications, including:
(i) the exhaust gas temperature of direct-flame incinerators
and/or the gas temperature immediately upstream and downstream of
any catalyst bed;
(ii) in Victoria County, the exhaust gas VOC concentration
of any carbon adsorption system, as defined in §115.10 of this
title (relating to Definitions), to determine if breakthrough has
occurred;
(iii) the total amount of VOC recovered by carbon adsorption
or other solvent recovery systems during a calendar month; or
(iv) the daily emission rate of VOC from the control
device;
(B) maintain a record of the dates and reasons for
any maintenance and repair of the required control devices and the
estimated quantity and duration of VOC emissions during such activities.
(3) The owner or operator of any pharmaceutical manufacturing
facility which is exempted from the requirements in accordance with
the provisions of §115.537(b) of this title (relating to Exemptions)
shall maintain a record of the following information, as appropriate:
(A) the vapor pressure of materials transferred at
loading facilities, stored in tanks, or processed in centrifuges and
filters; and
(B) the daily emissions rate of VOC.
(4) The owner or operator of any affected pharmaceutical
manufacturing facility shall maintain records of any testing conducted
at an affected facility in accordance with the provisions specified
in §115.535(b) of this title (relating to Testing Requirements).
(5) The owner or operator of any affected pharmaceutical
manufacturing facility shall maintain all records at the affected
facility for at least two years and make such records available upon
request to representatives of the executive director, EPA, or local
air pollution control agency.
|
Source Note: The provisions of this §115.536 adopted to be effective February 19, 1990, 15 TexReg 549; amended to be effective July 17, 1991, 16 TexReg 3729; amended to be effective August 1, 1992, 17 TexReg 4683; amended to be effective November 16, 1992, 17 TexReg 7782; amended to be effective May 22, 1997, 22 TexReg 4213; amended to be effective May 16, 2024, 49 TexReg 3292 |